ArticleInternational journal of molecular sciences2023

Resistance to BRAF Inhibitors: EZH2 and Its Downstream Targets as Potential Therapeutic Options in Melanoma.

Anne Uebel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.